()
has been a registered insider since 2003.
As Chief Financial Officer at Apellis Pharmaceuticals, last made a transaction on 4/1/2024.
InsiderInsights.com Purchase Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Purchases
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 2 |
50% |
-10% |
-10% |
39 |
1 Year |
2 |
0% |
-- |
-- |
-- |
| 2 |
50% |
1% |
1% |
44 |
9 Month |
2 |
0% |
-- |
-- |
-- |
| 2 |
50% |
3% |
3% |
59 |
6 Month |
2 |
0% |
-- |
-- |
-- |
| 2 |
50% |
2% |
2% |
15 |
3 Month |
2 |
0% |
-- |
-- |
-- |
| 2 |
50% |
1% |
1% |
27 |
1 Month |
2 |
0% |
-- |
-- |
-- |
| 2 |
100% |
8% |
8% |
12 |
1 Week |
2 |
0% |
-- |
-- |
-- |
InsiderInsights.com Sales Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Sales
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 3 |
100% |
-53% |
-55% |
14 |
1 Year |
3 |
0% |
-- |
-- |
-- |
| 8 |
100% |
-47% |
-50% |
27 |
9 Month |
8 |
0% |
-- |
-- |
-- |
| 9 |
100% |
-39% |
-38% |
21 |
6 Month |
9 |
0% |
-- |
-- |
-- |
| 9 |
89% |
-33% |
-36% |
58 |
3 Month |
9 |
0% |
-- |
-- |
-- |
| 9 |
67% |
-12% |
-4% |
76 |
1 Month |
9 |
0% |
-- |
-- |
-- |
| 9 |
44% |
0% |
1% |
12 |
1 Week |
9 |
0% |
-- |
-- |
-- |
| Scorecards Updated 12/17/2024 10:50 PM EST |
Latest Transaction Date: |
4/1/2024 |
| Average days between Transaction and Entered Dates: |
2 |
